Kolinpharma S.p.A.

BIT:KIP Lagerbericht

Marktkapitalisierung: €15.9m

Kolinpharma Management

Management Kriterienprüfungen 1/4

We currently do not have sufficient information about the CEO.

Wichtige Informationen

Rita Petrelli

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführerno data
Eigentum des Geschäftsführersn/a
Durchschnittliche Amtszeit des Managementskeine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder3.8yrs

Jüngste Management Updates

Recent updates

Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

Jun 17
Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Dec 01
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

Aug 25
An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Jun 08
We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

May 21
Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

May 03
Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

Apr 13
Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Feb 20
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Dec 28
Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

Nov 22
These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

Geschäftsführer

Rita Petrelli

no data

Amtszeit

Dr. Rita Paola Petrelli is the Co-Founder, Chairwoman of The Board, Chief Executive Officer and Chief Financial Officer of Kolinpharma S.p.A. Dr. Petrelli is chartered accountant, auditor and technical-leg...

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Rita Petrelli
Co-Founderno datakeine Datenkeine Daten
Massimo Mantella
CEO & Director4.4yrskeine Datenkeine Daten
Francesco Spano
Independent Directorno datakeine Datenkeine Daten
Pierluigi Pipolo
Chairman of the Board of Statutory Auditors3.8yrskeine Datenkeine Daten
Giannunzio Corazza
Non-Executive Directorno datakeine Datenkeine Daten
Edoardo Ferragina
Non-Executive Directorno datakeine Datenkeine Daten
Maurizio Altini
Independent Directorno datakeine Datenkeine Daten
Giulio Centemero
Standing Auditor3.8yrskeine Datenkeine Daten
Roberto Giannella
Standing Auditor3.8yrskeine Datenkeine Daten

3.8yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrener Vorstand: KIP's board of directors are considered experienced (3.8 years average tenure).